Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Mert

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
BMC Infectious Diseases|May 1, 2026
The impact of previous brucellosis treatment on the clinical course of neurobrucellosis: a multicentre retrospective studyOğuz Evlice, Ezgi Yılmaz, Murat Hakan Kır, et al.
European Geriatric Medicine|April 17, 2020
Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-STARTGulistan Bahat, Birkan Ilhan, Tugba Erdogan, et al.
Journal of Infection in Developing Countries|June 12, 2024
Diagnostic approach of tuberculous lymphadenitis in a multicenter studyErcan Yenilmez, Duygu Özakınsel, Adem Köse, et al.
Medical Mycology|June 24, 2024
Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI studyMeyha Sahin, Mesut Yilmaz, Ali Mert, et al.
Journal of Clinical Medicine|October 16, 2025
Clinical Outcomes of Cardiac Implantable Electronic Device-Related Endocarditis: An International ID-IRI StudySelda Aydin, Ali Mert, Ahmet Naci Emecen, et al.
Heliyon|July 31, 2024
Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI studyMeyha Sahin, Mesut Yilmaz, Ali Mert, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 23, 2026
Epidemiological profile and clinical outcomes of patients with mucormycosis: the multicenter retromucor study from Türkiye (2004-2024)Yeliz Çiçek, Rıdvan Dumlu, Mehmet Koçak, et al.
Rheumatology International|September 13, 2021
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controlsAli Mert, Haluk Vahaboğlu, Ferhat Arslan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|February 24, 2021
Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experienceBülent Değertekin, Mehmet Demir, Ulus S Akarca, et al.
Mycoses|January 12, 2024
Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID-19-associated candidemiaSelda Aydın, Ali Mert, Mesut Yılmaz, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
BMC Infectious Diseases|May 1, 2026
The impact of previous brucellosis treatment on the clinical course of neurobrucellosis: a multicentre retrospective studyOğuz Evlice, Ezgi Yılmaz, Murat Hakan Kır, et al.
European Geriatric Medicine|April 17, 2020
Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-STARTGulistan Bahat, Birkan Ilhan, Tugba Erdogan, et al.
Journal of Infection in Developing Countries|June 12, 2024
Diagnostic approach of tuberculous lymphadenitis in a multicenter studyErcan Yenilmez, Duygu Özakınsel, Adem Köse, et al.
Medical Mycology|June 24, 2024
Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI studyMeyha Sahin, Mesut Yilmaz, Ali Mert, et al.
Journal of Clinical Medicine|October 16, 2025
Clinical Outcomes of Cardiac Implantable Electronic Device-Related Endocarditis: An International ID-IRI StudySelda Aydin, Ali Mert, Ahmet Naci Emecen, et al.
Heliyon|July 31, 2024
Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI studyMeyha Sahin, Mesut Yilmaz, Ali Mert, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 23, 2026
Epidemiological profile and clinical outcomes of patients with mucormycosis: the multicenter retromucor study from Türkiye (2004-2024)Yeliz Çiçek, Rıdvan Dumlu, Mehmet Koçak, et al.
Rheumatology International|September 13, 2021
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controlsAli Mert, Haluk Vahaboğlu, Ferhat Arslan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|February 24, 2021
Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experienceBülent Değertekin, Mehmet Demir, Ulus S Akarca, et al.
Mycoses|January 12, 2024
Understanding clinical outcomes and factors influencing mortality in intensive care unit patients with COVID-19-associated candidemiaSelda Aydın, Ali Mert, Mesut Yılmaz, et al.
Pageof 25